These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 15762384)

  • 1. TNF antagonists for ankylosing spondylitis.
    Drug Ther Bull; 2005 Mar; 43(3):19-22. PubMed ID: 15762384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic therapies in the spondyloarthritis: new opportunities, new challenges.
    Braun J; Brandt J; Listing J; Rudwaleit M; Sieper J
    Curr Opin Rheumatol; 2003 Jul; 15(4):394-407. PubMed ID: 12819466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-modifying capacity of anti-tumour necrosis factor-alpha therapy in ankylosing spondylitis.
    De Keyser F; Baeten D; Van den Bosch F; Kruithof E; Verbruggen G; Mielants H; Veys E
    Drugs; 2004; 64(24):2793-811. PubMed ID: 15563249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study.
    Lie E; Kristensen LE; Forsblad-d'Elia H; Zverkova-Sandström T; Askling J; Jacobsson LT;
    Ann Rheum Dis; 2015 Jun; 74(6):970-8. PubMed ID: 25710471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biologics in the early treatment of ankylosing spondylitis and related forms of spondyloarthritis].
    Langer HE
    Wien Med Wochenschr; 2008; 158(7-8):200-5. PubMed ID: 18500471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etanercept and infliximab for rheumatoid arthritis.
    Drug Ther Bull; 2001 Jul; 39(7):49-52. PubMed ID: 11471515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-TNF-alpha treatment and spondyloarthropathies].
    Braun Y; Balbir-Gurman A
    Harefuah; 2002 Nov; 141(11):965-8, 1010. PubMed ID: 12476631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches.
    Braun J; Sieper J
    Arthritis Res; 2002; 4(5):307-21. PubMed ID: 12223105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological basis for the use of TNFalpha-blocking agents in ankylosing spondylitis and immunological changes during treatment.
    Zou JX; Braun J; Sieper J
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S34-7. PubMed ID: 12463444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A patient with ankylosing spondylitis who developed infliximab-induced lupus and treated with etanercept.
    Akgül Ö; Kılıç G; Kılıç E; Cüce İ; Özgöçmen S
    Rheumatol Int; 2014 Mar; 34(3):443-4. PubMed ID: 23263496
    [No Abstract]   [Full Text] [Related]  

  • 11. Etanercept: new indication. For ankylosing spondylitis: another option.
    Prescrire Int; 2005 Jun; 14(77):92-3. PubMed ID: 15981387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of antitumor necrosis factor(α) agents on patients with ankylosing spondylitis.
    Ren L; Li J; Luo R; Tang R; Zhu S; Wan L
    Am J Med Sci; 2013 Dec; 346(6):455-61. PubMed ID: 23715113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of ankylosing spondylitis with anti-TNFalpha agents].
    Bontoux D; Azaïs I; Goupille P
    Bull Acad Natl Med; 2006; 190(4-5):981-92; discussion 993-4. PubMed ID: 17195622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The change of bone mineral density according to treatment agents in patients with ankylosing spondylitis.
    Kang KY; Lee KY; Kwok SK; Ju JH; Park KS; Hong YS; Kim HY; Park SH
    Joint Bone Spine; 2011 Mar; 78(2):188-93. PubMed ID: 20621536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug insight: anti-tumor-necrosis-factor therapy for ankylosing spondylitis.
    Henderson C; Davis JC
    Nat Clin Pract Rheumatol; 2006 Apr; 2(4):211-8. PubMed ID: 16932687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-nuclear antibodies, anti-DNA and C4 complement evolution in rheumatoid arthritis and ankylosing spondylitis treated with TNF-alpha blockers.
    Gonnet-Gracia C; Barnetche T; Richez C; Blanco P; Dehais J; Schaeverbeke T
    Clin Exp Rheumatol; 2008; 26(3):401-7. PubMed ID: 18578960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-TNF alpha in the treatment of rheumatoid arthritis and ankylosing spondylitis].
    Lanfant-Weybel K; Lequerré T; Vittecoq O
    Presse Med; 2009 May; 38(5):774-87. PubMed ID: 19327945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumour necrosis factor (TNF)-alpha therapy in undifferentiated spondyloarthropathy.
    Schnarr S; Kuipers JG; Zeidler H
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S126-9. PubMed ID: 12463462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of biologic agents in the therapy of ankylosing spondylitis].
    Géher P; Nagy MB; Péntek M; Tóth E; Brodszky V; Gulácsi L
    Orv Hetil; 2006 Jul; 147(26):1203-13. PubMed ID: 16898082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha.
    Gorman JD; Sack KE; Davis JC
    N Engl J Med; 2002 May; 346(18):1349-56. PubMed ID: 11986408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.